Example: Heart Attack
Clinical Trials on Ichthyosis, X-Linked
Total 62 results
-
NCT04541355Not yet recruitingConditions: Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Locally Advanced Head and Neck Squamous Cell Carcinoma; Locally Advanced Hypopharyngeal Squamous Cell Carcinoma; Locally Advanced Laryngeal Squamous Cell Carcinoma; Locally Advanced Oral Cavity Squamous Cell Carcinoma; Locally Advanced Oropharyngeal Squamous Cell Carcinoma; Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Stage III Hypopharyngeal Carcinoma AJCC v8; Stage III Laryngeal Cancer AJCC v8; Stage III Lip and Oral Cavity Cancer AJCC v8; Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IV Hypopharyngeal Carcinoma AJCC v8; Stage IV Laryngeal Cancer AJCC v8; Stage IV Lip and Oral Cavity Cancer AJCC v8; Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVA Hypopharyngeal Carcinoma AJCC v8; Stage IVA Laryngeal Cancer AJCC v8; Stage IVA Lip and Oral Cavity Cancer AJCC v8; Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVB Hypopharyngeal Carcinoma AJCC v8; Stage IVB Laryngeal Cancer AJCC v8; Stage IVB Lip and Oral Cavity Cancer AJCC v8; Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVC Hypopharyngeal Carcinoma AJCC v8; Stage IVC Laryngeal Cancer AJCC v8; Stage IVC Lip and Oral Cavity Cancer AJCC v8; Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
-
NCT04406649RecruitingConditions: Migraine; Migraine With Aura; Migraine Without Aura
-
NCT04167579RecruitingConditions: Transcutaneous Valve Therapies
-
NCT04166006RecruitingConditions: Head Neck Tumors; Neuroendocrine Tumors; Soft Tissue Sarcoma; Rare Cancer; Vaccination
-
NCT04032964Not yet recruitingConditions: Soft Tissue Sarcoma
-
NCT03901482CompletedConditions: Migraine; Migraine With Aura; Migraine Without Aura
-
NCT03874832CompletedConditions: Migraine With Aura; Migraine Without Aura; Migraine
-
NCT03819985RecruitingConditions: Resectable Soft Tissue Sarcoma; Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
-
NCT03799133CompletedConditions: Cardiac Failure; Ventricular Dysfunction; Valvular Heart Disease
-
NCT03786640RecruitingConditions: Syncope; Presyncope; Fatigue; Disorientation; Arrythmia; Bradycardia
-
NCT03627624CompletedConditions: COPD
-
NCT03420014RecruitingConditions: Unresectable or Metastatic Soft Tissue Sarcoma
-
NCT03321357CompletedConditions: Degenerative Disc Disease; Spondylolisthesis; Spondylosis; Herniated Nucleus Pulposus; Spinal Stenosis Lumbar; Spinal Diseases; Spinal Instability
-
NCT03268772Active, not recruitingConditions: Soft Tissue Sarcoma
-
NCT03217266RecruitingMDM2 Inhibitor AMG-232 (KRT-232) and Radiation Therapy in Treating Patients With Soft Tissue SarcomaConditions: Soft Tissue Sarcoma
-
NCT03138161RecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaConditions: Advanced Soft Tissue Sarcoma; Metastatic Soft Tissue Sarcoma
-
NCT03126591Active, not recruitingConditions: Soft Tissue Sarcoma
-
NCT03121846Unknown statusConditions: Soft Tissue Sarcoma, Adult, Stage II
-
NCT03112980RecruitingConditions: Aortic Valve Stenosis
-
NCT03108300Not yet recruitingConditions: Malignant Soft Tissue Sarcoma
-
NCT03064243Unknown statusConditions: Soft Tissue Sarcoma
-
NCT03042819Active, not recruitingConditions: Soft Tissue Sarcoma
-
NCT03022448RecruitingConditions: Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue Sarcoma
-
NCT02929394TerminatedConditions: Sarcoma, Soft Tissue
-
NCT02910895RecruitingConditions: Soft Tissue Sarcoma; Xenograft Model; 2D/3D Cell Cultures
-
NCT02864082CompletedConditions: Congenital Ichthyosis
-
NCT02636725Active, not recruitingConditions: Alveolar Soft Part Sarcoma; Soft Tissue Sarcomas
-
NCT02618122CompletedConditions: Advanced Soft Tissue Sarcoma
-
NCT02571036RecruitingConditions: Gastrointestinal Stromal Tumors; Advanced Systemic Mastocytosis; Advanced Cancers
-
NCT02565498RecruitingConditions: Adult Soft Tissue Sarcoma
-
NCT02549937RecruitingConditions: Tumors
-
NCT02451943Active, not recruitingConditions: Soft Tissue Sarcoma
-
NCT02449343Unknown statusConditions: Soft Tissue Sarcoma
-
NCT02367651WithdrawnConditions: Sarcoma, Soft Tissue
-
NCT02247544CompletedConditions: Liposarcoma; Leiomyosarcoma
-
NCT02245763RecruitingConditions: Mitral Valve Regurgitation
-
NCT02066675CompletedConditions: Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive; Standard Chemotherapy
-
NCT02046304CompletedConditions: Sarcoma
-
NCT01995981CompletedConditions: Sarcoma, Soft Tissue
-
NCT01975519CompletedConditions: Advanced Soft Tissue Sarcoma
-
NCT01918904WithdrawnConditions: Calcinosis Cutis
-
NCT01878448CompletedConditions: Cancer
-
NCT01737528RecruitingConditions: Aortic Valve Stenosis
-
NCT01594203Unknown statusConditions: Soft Tissue Sarcoma (STS)
-
NCT01431222Unknown statusConditions: Mitral Regurgitation
-
NCT01418001TerminatedConditions: Sarcoma; Leiomyosarcoma; Malignant Peripheral Nerve Sheath Tumor; Malignant Fibrous; Histiocytoma/Undifferentiated Pleomorphic Sarcoma
-
NCT01369641TerminatedConditions: Cancer
-
NCT01347034CompletedConditions: Soft Tissue Sarcoma
-
NCT01299506CompletedConditions: Soft Tissue Sarcoma
-
NCT01104298TerminatedConditions: Sarcoma